Risk: High

a1m

A1M: Copper Miner - Jericho's Make-or-Break Moment

Updated 8 Oct 2025

Development-stage copper producer with fair value A$0.289 vs current A$0.32. Binary Jericho execution risk with 70% combined failure probability creates unfavourable risk-reward for conservative investors.

View note

thl

THL: RV Rental Giant - Tourism's Sleeping Beauty Awakens

Updated 8 Oct 2025

Global #1 RV rental operator trading at $2.02 vs $6.55 fair value (224% upside). Tourism recovery from 85% to 100%+ of 2019 levels drives fleet utilisation and margin expansion, though execution risks remain.

View note

tgp

TGP: Dual-Platform Pioneer - Special Distribution, Special Problems

Updated 8 Oct 2025

SELL rating with fair value $0.40 vs current $0.62. EBITDA margins compressing from 60.9% to 44% as competitive threats emerge.

View note

sig

SIG: Pharmacy Powerhouse - Merger Magic Meets Market Madness

Updated 8 Oct 2025

Sigma Healthcare trades at $3.03 versus $1.33 fair value (56% downside). Strong integration progress but extreme overvaluation at 32.5x EV/EBITDA.

View note

rmy

RMY: PropTech Platform - Price Check Required Before Checkout

Updated 8 Oct 2025

RMA Global trades at $3.50 vs $0.170 fair value assessment. Platform transformation achieving positive cash flow with 35% revenue growth potential through US expansion. Price verification critical.

View note

pyc

PYC: RNA Therapeutics Pioneer - Platform Validated, Value Undervalued

Updated 8 Oct 2025

Clinical-stage RNA therapeutics with validated platform technology trading at $1.26 versus $14.41 fair value, offering 1,044% upside potential for growth investors.

View note

nhf

NHF: Health Insurer - Transformation Prescription Needs Filling

Updated 8 Oct 2025

Australia's #4 health insurer trades 15% above A$6.48 fair value. Strong 15.1% ROIC offset by transformation execution risks. Quality franchise, challenging outlook.

View note

mac

MAC: Copper Mining Champion - Harmony's Golden Handcuffs

Updated 8 Oct 2025

High-grade copper miner trading at $18.55 vs $12.73 fair value. EBITDA margins 49.4%, ROIC 16.8%. Harmony acquisition pending at 46% premium.

View note

lov

LOV: Fast-Fashion Jewellery Giant - Margin Mirage Meets Reality Check

Updated 8 Oct 2025

Strong sell recommendation with 47% downside to $21.77 fair value. Exceptional margins unsustainable as competition intensifies.

View note

jin

JIN: Digital Lottery Leader - Contract Cliff Countdown Begins

Updated 8 Oct 2025

Jumbo Interactive trades at $11.39 vs $10.37 fair value. Strong 47% margins offset by 69% TLC dependency and 2030 renewal risk.

View note

imu

IMU: Biotech Breakthrough - CAR T Revolution or Clinical Mirage?

Updated 8 Oct 2025

Clinical-stage biotechnology with 79% Phase 1b response rate trading at $0.275 versus $4.12 fair value, offering 1,371% upside through allogeneic CAR T platform advantages.

View note

gyg

GYG: Mexican QSR Leader - Clean Food, Dirty Valuation

Updated 8 Oct 2025

High-quality Australian restaurant business with 45% market share trading at 35% premium to $16.22 fair value, requiring extraordinary execution to justify current pricing

View note